Martin A. Lehr, Chief Executive Officer at Context Therapeutics Inc. (CNTX), bought 20,000 shares at $0.74 ($15K) on 2022-12-16, disclosed to the SEC on 2022-12-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CNTX | BUY | 2023-02-13 | $5K | — | Filing → |
| CNTX | BUY | 2023-02-06 | $5K | — | Filing → |
| CNTX | BUY | 2023-01-30 | $5K | — | Filing → |